Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly
- PMID: 22252007
- DOI: 10.4161/hv.8.1.17622
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly
Abstract
Influenza epidemics and pandemics carry a heavy socioeconomic burden. Hospitalization and treatment are more often necessary in high-risk patients, such as the elderly. However, the impact of influenza is not negligible even in adults, mainly because of lost productivity. The World Health Organization estimates that seasonal influenza causes 250,000-500,000 deaths worldwide each year; however, mortality may be very high in pandemic periods. Many estimates of the costs of seasonal influenza have been made in various socioeconomic contexts. For instance, among the adult population in Italy, a cost of €940.39 per case has been estimated. In the US, the average annual influenza burden in 18-49-y-old adults without underlying medical conditions is judged to include approximately 32,000 hospitalizations and 680 deaths. Estimating the influenza burden is a useful aid to determining the best influenza vaccination strategy and preventive and clinical treatments.
Similar articles
-
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.Vaccine. 2006 Nov 17;24(47-48):6812-22. doi: 10.1016/j.vaccine.2006.07.042. Epub 2006 Aug 4. Vaccine. 2006. PMID: 17034909
-
The annual impact of seasonal influenza in the US: measuring disease burden and costs.Vaccine. 2007 Jun 28;25(27):5086-96. doi: 10.1016/j.vaccine.2007.03.046. Epub 2007 Apr 20. Vaccine. 2007. PMID: 17544181
-
[Estimation of the excess death associated with influenza pandemics and epidemics in Japan after world war II: relation with pandemics and the vaccination system].Nihon Koshu Eisei Zasshi. 2011 Oct;58(10):867-78. Nihon Koshu Eisei Zasshi. 2011. PMID: 22352000 Japanese.
-
Clinical and socioeconomic impact of pediatric seasonal and pandemic influenza.Hum Vaccin Immunother. 2012 Jan;8(1):17-20. doi: 10.4161/hv.8.1.18145. Epub 2012 Jan 1. Hum Vaccin Immunother. 2012. PMID: 22252002 Review.
-
The ins and outs of universal childhood influenza vaccination.Future Microbiol. 2011 Oct;6(10):1171-84. doi: 10.2217/fmb.11.106. Future Microbiol. 2011. PMID: 22004036 Review.
Cited by
-
Hospital admissions for pyoderma gangrenosum in Spain (1999-2021): Epidemiological and clinical characteristics, temporal trends, and factors associated with poor prognosis and higher cost.Health Sci Rep. 2024 Oct 8;7(10):e2286. doi: 10.1002/hsr2.2286. eCollection 2024 Oct. Health Sci Rep. 2024. PMID: 39381532 Free PMC article.
-
Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season.Hum Vaccin Immunother. 2023 Dec 31;19(1):2190279. doi: 10.1080/21645515.2023.2190279. Epub 2023 Mar 15. Hum Vaccin Immunother. 2023. PMID: 36919537 Free PMC article.
-
Expert-novice differences in mental models of viruses, vaccines, and the causes of infectious disease.Public Underst Sci. 2015 Feb;24(2):241-56. doi: 10.1177/0963662513496954. Epub 2013 Aug 19. Public Underst Sci. 2015. PMID: 23959975 Free PMC article.
-
Long Short-term Memory-Based Prediction of the Spread of Influenza-Like Illness Leveraging Surveillance, Weather, and Twitter Data: Model Development and Validation.J Med Internet Res. 2023 Feb 6;25:e42519. doi: 10.2196/42519. J Med Internet Res. 2023. PMID: 36745490 Free PMC article.
-
Seasonal influenza vaccination among older adults in Jordan: prevalence, knowledge, and attitudes.Hum Vaccin Immunother. 2020 Sep 1;16(9):2252-2256. doi: 10.1080/21645515.2020.1718438. Epub 2020 Feb 11. Hum Vaccin Immunother. 2020. PMID: 32045332 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical